Pivotal's Tim Ramey Publishes Midday Note Saying Post Consumer Brands Should Be Soaring As Company Is Getting Weetabix For Free, Believes Weetabix Will Add E$120M Of EBITDA To FY18 Results With No Corresponding Increase In Int. Expense